Comparing the Side-lying Sleep Positioning to Back-lying in Infants With Cleft Palate
Launched by MANCHESTER UNIVERSITY NHS FOUNDATION TRUST · Jul 16, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best sleep position for infants with cleft palate, specifically comparing side-lying (on their side) to back-lying (on their back). Babies with cleft palate often face challenges like obstructive sleep apnea (OSA), which can affect their breathing and overall development. This study aims to find out if sleeping on their side can help reduce breathing problems during sleep and support better growth and development in these infants.
To participate in this trial, infants must be between 3 to 5 weeks old and diagnosed with an isolated cleft palate. Unfortunately, infants with cleft lip, those born prematurely, or those with certain medical conditions won't be eligible. Parents who join the study can expect to provide consent and follow specific procedures to help researchers understand how different sleeping positions affect their baby's oxygen levels during sleep. This research is important because it seeks to provide clearer guidance to parents about the best sleep position for their babies, helping to reduce the risks associated with sleep apnea and improve their child's development.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants diagnosed with an isolated CP under the care of a collaborating centre
- • Infants who are 3 to 5 weeks of age when monitored
- • Parents willing to give consent and able to complete study procedures
- Exclusion Criteria:
- • Infants with associated cleft lip
- • Infants born prematurely (before 37 week gestation or up to and including 36 weeks and 6 days)
- • Infants with cardiorespiratory disease
- • Infants requiring an intervention to assist with breathing (nasopharyngeal airway)
- • Infants requiring an intervention to assist with feeding (nasogastric tube)
About Manchester University Nhs Foundation Trust
Manchester University NHS Foundation Trust is a leading healthcare organization dedicated to delivering exceptional patient care and advancing medical research. As an integral part of the UK's National Health Service, the Trust encompasses a range of hospitals and services, fostering innovation in clinical research and trials. With a strong emphasis on collaboration and excellence, Manchester University NHS Foundation Trust is committed to improving health outcomes through rigorous scientific investigation and the translation of research findings into practice, ensuring that patients benefit from the latest advancements in medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeds, , United Kingdom
Nottingham, , United Kingdom
Cambridge, , United Kingdom
Liverpool, , United Kingdom
Nottingham, , United Kingdom
London, , United Kingdom
Newcastle Upon Tyne, , United Kingdom
Bristol, , United Kingdom
Birmingham, , United Kingdom
Manchester, , United Kingdom
Salisbury, , United Kingdom
Swansea, , United Kingdom
Patients applied
Trial Officials
Iain Bruce, Prof
Study Director
Manchester University NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials